Hyundai Pharm (004310) — Cash Flow Reinvestment Rate
Hyundai Pharm (004310) has a Cash Flow Reinvestment Rate of 14.79x as of February 2026, reinvesting ₩2.78 Billion (capex ₩2.59 Billion plus investments ₩192.05 Million) from operating cash flow of ₩188.28 Million. Check 004310 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Hyundai Pharm Cash Flow Reinvestment Rate (2010–2022)
Historical reinvestment intensity for Hyundai Pharm across 8 annual periods. Explore how much of Hyundai Pharm's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Hyundai Pharm (2010–2022)
Year-by-year capital reinvestment analysis for Hyundai Pharm. For live market cap and broader valuation context, see 004310 stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 1.43x | ₩16.57 Billion | ₩11.62 Billion | ₩6.58 Billion | ▲ +7.0% |
| 2021 | 1.33x | ₩6.84 Billion | ₩5.13 Billion | ₩6.81 Billion | ▼ -23.4% |
| 2020 | 1.74x | ₩18.79 Billion | ₩10.80 Billion | ₩6.40 Billion | ▲ +138.0% |
| 2019 | 0.73x | ₩5.09 Billion | ₩6.96 Billion | ₩2.36 Billion | ▼ -74.6% |
| 2018 | 2.87x | ₩8.14 Billion | ₩2.83 Billion | ₩2.67 Billion | ▲ +727.5% |
| 2013 | 0.35x | ₩2.76 Billion | ₩7.95 Billion | ₩2.24 Billion | ▼ -45.2% |
| 2011 | 0.63x | ₩3.97 Billion | ₩6.27 Billion | ₩3.68 Billion | ▼ -58.9% |
| 2010 | 1.54x | ₩4.13 Billion | ₩2.68 Billion | ₩3.95 Billion | — |